Apolipoprotein A (APOA) seems to be a good indicator of several cancers, such as colon, hepatocellular, and pancreatic cancer; meanwhile, apolipoprotein E (APOE) may have polymorphisms that affect tumor susceptibility. This evidence concerns the gene APOA1 and pancreatic neoplasm.